Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NR1H4 | Q96RI1 | 20/20 | 0.65 |
| ▸ | NR1I2 | O75469 | 3/20 | 0.51 |
| ▸ | CYP2C9 | P11712 | 3/20 | 0.51 |
| ▸ | CYP2C19 | P33261 | 3/20 | 0.51 |
| ▸ | ABCB11 | O95342 | 1/20 | 0.44 |
| ▸ | UGT1A1 | P22309 | 1/20 | 0.44 |
| ▸ | FXR2 | P51116 | 1/20 | 0.44 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.44 |
| ▸ | SLCO1B3 | Q9NPD5 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL22350333 | 0.92 | NR1H4 (0.78) | NR1H4 | |
| SCHEMBL29900863 | 0.92 | NR1H4 (0.78) | NR1H4 | |
| SCHEMBL22348250 | 0.87 | NR1H4 (0.84) | NR1H4NR1I2CYP2C9CYP2C19 | |
| SCHEMBL22347991 | 0.87 | NR1H4 (0.84) | NR1H4NR1I2CYP2C9CYP2C19 | |
| SCHEMBL22348176 | 0.83 | NR1H4 (0.83) | NR1H4NR1I2CYP2C9CYP2C19 | |
| SCHEMBL22347942 | 0.83 | NR1H4 (0.70) | NR1H4NR1I2CYP2C9CYP2C19 | |
| SCHEMBL22348058 | 0.83 | NR1H4 (0.78) | NR1H4NR1I2CYP2C9CYP2C19 | |
| SCHEMBL22347624 | 0.81 | NR1H4 (0.83) | NR1H4 | |
| SCHEMBL22348223 | 0.80 | NR1H4 (0.73) | NR1H4NR1I2CYP2C9CYP2C19 | |
| SCHEMBL22347805 | 0.80 | NR1H4 (0.69) | NR1H4NR1I2CYP2C9CYP2C19 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3924329-A2 | SUBSTITUTED AMIDE COMPOUNDS USEFUL AS FARNESOID X RECEPTOR MODULATORS | Bristol-Myers Squibb Company (US) | 2021-12-22 | — | — | EP | claimed |
| WO-2020168152-A2 | SUBSTITUTED AMIDE COMPOUNDS USEFUL AS FARNESOID X RECEPTOR MODULATORS | BRISTOL-MYERS SQUIBB COMPANY (US) | 2020-08-20 | — | — | WO | claimed |
| EP-3924329-A2 | SUBSTITUTED AMIDE COMPOUNDS USEFUL AS FARNESOID X RECEPTOR MODULATORS | Bristol-Myers Squibb Company (US) | 2021-12-22 | — | — | EP | disclosed |
| WO-2020168152-A2 | SUBSTITUTED AMIDE COMPOUNDS USEFUL AS FARNESOID X RECEPTOR MODULATORS | BRISTOL-MYERS SQUIBB COMPANY (US) | 2020-08-20 | — | — | WO | disclosed |